These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15193808)

  • 1. The impact of Sirolimus Eluting stents in interventional cardiology.
    Di Mario C; Griffiths H; O'Rourke B; Kaddoura S
    Int J Cardiol; 2004 Jun; 95(2-3):117-21. PubMed ID: 15193808
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus-eluting stents: does a great stent still need a good interventionalist?
    Carrozza JP
    J Am Coll Cardiol; 2004 Mar; 43(6):1116-7. PubMed ID: 15028376
    [No Abstract]   [Full Text] [Related]  

  • 4. The dollars and sense of drug-eluting stents.
    Brophy JM
    CMAJ; 2005 Feb; 172(3):361-2. PubMed ID: 15684119
    [No Abstract]   [Full Text] [Related]  

  • 5. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

  • 6. Sirolimus-eluting coronary stents.
    Sharma S; Bhambi B; Nyitray W
    N Engl J Med; 2002 Oct; 347(16):1285; author reply 1285. PubMed ID: 12393833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent trend in interventional cardiology--drug-containing stents].
    Kipshidze N; Moses JW; Serruys PW; Colombo A; Kipshidze NN; Leon MB
    Ter Arkh; 2003; 75(9):89-94. PubMed ID: 14582443
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
    Er F; Erdmann E
    Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
    Gil RJ
    Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
    [No Abstract]   [Full Text] [Related]  

  • 11. TCT Daily: ZOMAXX I--mixed results with zotarolimus-eluting stent.
    J Interv Cardiol; 2007 Feb; 20(1):35. PubMed ID: 17300399
    [No Abstract]   [Full Text] [Related]  

  • 12. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
    Beijk MA; Piek JJ
    Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug eluting stents: case study in the acceptance of a new medical technology.
    Klein LW; Hodgson JM;
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):528-30. PubMed ID: 15789397
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving beyond the cost per quality-adjusted life year: modelling the budgetary impact and clinical outcomes associated with the use of sirolimus-eluting stents.
    Shrive FM; Ghali WA; Lewis S; Donaldson C; Knudtson ML; Manns BJ
    Can J Cardiol; 2005 Jul; 21(9):783-7. PubMed ID: 16082437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards defining the role of drug eluting stents.
    Tarantini G; Ramondo A; Razzolini R
    Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous coronary intervention and drug-eluting stents.
    Yang YM; Moussa I
    CMAJ; 2005 Feb; 172(3):323-5. PubMed ID: 15684110
    [No Abstract]   [Full Text] [Related]  

  • 20. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents.
    Lowe HC; Schwartz RS; Mac Neill BD; Jang IK; Hayase M; Rogers C; Oesterle SN
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):515-23. PubMed ID: 14624433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.